Skyhawk Therapeutics, Inc.
Clinical trials sponsored by Skyhawk Therapeutics, Inc., explained in plain language.
-
Breakthrough pill aims to slow devastating brain disease
Disease control Recruiting nowThis clinical trial is testing whether a new oral medication called SKY-0515 can reduce harmful proteins in the brain and improve symptoms for people with Huntington's Disease. The study will involve 120 adults with genetically confirmed Huntington's who will take either the drug…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Breakthrough Huntington's pill aims to slow devastating brain disease
Disease control Recruiting nowThis study is testing whether a new oral medication called SKY-0515 can slow the progression of Huntington's Disease by reducing harmful proteins in the brain. The trial will involve 400 adults aged 25+ with genetically confirmed Huntington's who are still fairly independent. Par…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC